United States · Series B startup
4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$89Mraised across 4 rounds since 2010, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by elevationpharma.comSEC filing: $12M sold, first sale Dec 2011
No investor was named in the report.
Reported by sec.govSEC filing: $12M sold, first sale Dec 2011
Reported by xconomy.comSEC filing: $12M sold, first sale Dec 2011
Reported by finsmes.comSEC filing: $15M sold, first sale Jan 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
CanaanCare Capital
Mesa Verde Venture PartnersTPG Sourcing Advisors, LLC
TPG
Novo HoldingsFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
Elevation Pharmaceuticals's investors include Canaan, Care Capital, Mesa Verde Venture Partners, TPG Sourcing Advisors, LLC and TPG, and 1 more on record.
Elevation Pharmaceuticals has raised $89M across 4 rounds since 2010.
Elevation Pharmaceuticals's most recent round was a Series B of $30M in Jan 2012.
Its most recent round, $30M in Jan 2012, is also its largest on record.
Elevation Pharmaceuticals's first round on record, in Jan 2010, was backed by Canaan, TPG Sourcing Advisors, LLC and Care Capital and 1 others.
Elevation Pharmaceuticals's latest named round is a Series B, in Jan 2012.
Elevation Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·